Get the Stockscreener App
1.55
18.42%
-0.35
After Hours:
1.60
0.05
+3.23%
Conduit Pharmaceuticals Inc Stock (CDT) Forecast
The Conduit Pharmaceuticals Inc (CDT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.317, representing a +178.52% increase from the current price of $1.55. The highest analyst price target is $4.2826, and the lowest is $4.3514.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CDT Price Target
Average 3.6765
(+137.19% Upside)
Is Conduit Pharmaceuticals Inc (CDT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.68 | Buy |
| STOCH(9,6) | 2.3939 | Buy |
| STOCHRSI(14) | 4.5559 | Buy |
| MACD(12,26) | -1.6971 | Sell |
| ADX(14) | 21.30 | Neutral |
| William %R | -98.39 | Buy |
| CCI(14) | -47.19 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.613
Sell
|
2.8811
Sell
|
| MA20 |
5.313
Sell
|
4.3109
Sell
|
| MA50 |
7.0668
Sell
|
7.1072
Sell
|
| MA100 |
9.026
Sell
|
21.47
Sell
|
| MA200 |
73.66
Sell
|
78.10
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CDT could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CDT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.68 indicates that CDT is oversold. This indicates that CDT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 2.3939 indicates that CDT is oversold. This indicates that CDT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.5559 indicates that CDT is oversold. This suggests that CDT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.3 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -47.19 indicates that CDT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CDT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Conduit Pharmaceuticals Inc financial reports and earnings history, Conduit Pharmaceuticals Inc (CDT) stock could reach $24.96 by 2030, $67.17 by 2040 and $103.43 by 2050. See the projected annual prices until 2050 of the Conduit Pharmaceuticals Inc stock below:
- Conduit Pharmaceuticals Inc (CDT) is expected to reach an average price of $45.00 in 2035, with a high prediction of $46.11 and a low estimate of $45.54. This indicates an $2,803% rise from the last recorded price of $1.55.
- Conduit Pharmaceuticals Inc (CDT) stock is projected to chart a bullish course in 2040, with an average price target of $64.99, representing an $4,093% surge from its current level. The forecast ranges from a conservative $65.12 to a sky-high $67.17.
- Our analysts predict Conduit Pharmaceuticals Inc (CDT) to jump 5,221% by 2045, soaring from $82.66 to an average price of $82.47, potentially reaching $85.87. While $82.66 is the low estimate, the potential upside is significant.
- Conduit Pharmaceuticals Inc (CDT) stock is expected to climb by 2050, reaching an average of $95.25, a $6,045% jump from its current level. However, a wide range of estimates exists, with high and low targets of $103.43 and $98.22, respectively, highlighting the market's uncertainty.
Conduit Pharmaceuticals Inc Stock (CDT) Year by Year Forecast
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2025
Conduit Pharmaceuticals Inc Stock (CDT) is expected to reach an average price of $3.6765 in 2025, with a high prediction of $7.221 and a low estimate of $0.1321. This indicates an +137.19% rise from the last recorded price of $1.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $3.6514 | $4.3514 | $4.2826 | +135.58% |
| April, 2025 | $0.2022 | $0.1321 | $2.6979 | -86.95% |
| May, 2025 | $1.8229 | $0.5325 | $0.5929 | +17.60% |
| June, 2025 | $1.5735 | $1.9133 | $1.6333 | +1.52% |
| July, 2025 | $1.0943 | $1.3643 | $1.0339 | -29.40% |
| August, 2025 | $0.2549 | $0.4049 | $0.3152 | -83.55% |
| September, 2025 | $0.1456 | $0.1456 | $0.3344 | -90.61% |
| October, 2025 | $7.5857 | $0.2457 | $6.8657 | +389.40% |
| November, 2025 | $7.2667 | $7.4167 | $7.221 | +368.82% |
| December, 2025 | $2.6829 | $3.5676 | $7.0732 | +73.09% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2026
The predicted value for Conduit Pharmaceuticals Inc (CDT) in 2026 is set at an average of $5.9573. Estimates vary from a peak of $10.19 to a trough of $1.7233, indicating an +284.34% surge from the present price of $1.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.1038 | $2.6981 | $2.0038 | +35.73% |
| February, 2026 | $4.1348 | $3.4441 | $3.5548 | +166.76% |
| March, 2026 | $3.4057 | $3.6057 | $3.84 | +119.72% |
| April, 2026 | $2.2419 | $2.4919 | $2.9614 | +44.64% |
| May, 2026 | $1.8829 | $2.0829 | $1.8476 | +21.48% |
| June, 2026 | $6.63 | $1.7233 | $4.59 | +327.74% |
| July, 2026 | $9.8916 | $9.7703 | $10.19 | +538.17% |
| August, 2026 | $9.1429 | $9.8429 | $9.8638 | +489.86% |
| September, 2026 | $5.2444 | $5.2641 | $4.8705 | +238.35% |
| October, 2026 | $6.5057 | $5.3951 | $5.2757 | +319.72% |
| November, 2026 | $5.897 | $6.237 | $6.0467 | +280.45% |
| December, 2026 | $4.9686 | $5.2386 | $5.1777 | +220.55% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Conduit Pharmaceuticals Inc (CDT) is $9.7165, with a high forecast of $16.13 and a low forecast of $3.3011. This indicates an +526.87% increase from the last price of $1.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.7699 | $3.9199 | $3.8569 | +143.22% |
| February, 2027 | $3.3011 | $3.3011 | $3.5602 | +112.98% |
| March, 2027 | $13.62 | $3.3114 | $12.90 | +778.46% |
| April, 2027 | $12.94 | $13.09 | $13.16 | +734.70% |
| May, 2027 | $7.7694 | $8.8794 | $12.65 | +401.25% |
| June, 2027 | $6.9664 | $7.8264 | $7.0548 | +349.44% |
| July, 2027 | $8.6379 | $8.2168 | $8.0579 | +457.29% |
| August, 2027 | $7.5495 | $7.7495 | $8.2533 | +387.07% |
| September, 2027 | $5.9365 | $6.1865 | $6.9103 | +283.00% |
| October, 2027 | $5.2181 | $5.4181 | $5.2727 | +236.65% |
| November, 2027 | $12.93 | $4.8443 | $10.89 | +734.19% |
| December, 2027 | $15.74 | $15.98 | $16.13 | +915.64% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2028
In 2028, Conduit Pharmaceuticals Inc (CDT) is projected to reach an average price of $12.74, with a high projection of $19.10 and a low estimate of $6.3772. This indicates an +721.92% rise from the last price of $1.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $14.63 | $15.33 | $15.52 | +844.15% |
| February, 2028 | $8.3362 | $10.40 | $10.18 | +437.82% |
| March, 2028 | $11.19 | $10.26 | $9.9586 | +621.84% |
| April, 2028 | $10.22 | $10.56 | $10.46 | +559.39% |
| May, 2028 | $8.8429 | $9.1129 | $9.351 | +470.51% |
| June, 2028 | $7.2848 | $7.4348 | $7.6413 | +369.99% |
| July, 2028 | $6.4567 | $6.4567 | $6.9853 | +316.56% |
| August, 2028 | $19.65 | $6.3772 | $18.93 | +1,168% |
| September, 2028 | $18.61 | $18.76 | $19.10 | +1,101% |
| October, 2028 | $13.08 | $14.19 | $18.24 | +743.94% |
| November, 2028 | $11.83 | $12.69 | $12.28 | +663.15% |
| December, 2028 | $13.14 | $12.99 | $12.65 | +747.81% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2029
The 2029 price forecast for Conduit Pharmaceuticals Inc Stock (CDT) is $14.99 on average, with a high prediction of $22.07 and a low estimate of $7.91. This represents an +867.18% increase from the previous price of $1.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.62 | $11.63 | $12.67 | +649.61% |
| February, 2029 | $9.6311 | $9.8811 | $10.87 | +521.36% |
| March, 2029 | $8.5534 | $8.7534 | $8.6978 | +451.83% |
| April, 2029 | $19.23 | $7.91 | $17.19 | +1,141% |
| May, 2029 | $21.59 | $22.13 | $22.07 | +1,293% |
| June, 2029 | $20.13 | $20.83 | $21.19 | +1,198% |
| July, 2029 | $13.47 | $15.53 | $15.49 | +768.92% |
| August, 2029 | $15.87 | $15.12 | $14.64 | +923.96% |
| September, 2029 | $14.54 | $14.88 | $14.94 | +838.32% |
| October, 2029 | $12.72 | $12.99 | $13.58 | +720.46% |
| November, 2029 | $10.80 | $10.95 | $11.43 | +596.76% |
| December, 2029 | $9.6122 | $9.6122 | $10.41 | +520.14% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2030
Conduit Pharmaceuticals Inc Stock (CDT) is expected to reach an average price of $18.73 in 2030, with a high forecast of $28.01 and a low forecast of $9.4429. This signifies an +1,108% surge from the last price of $1.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $25.68 | $9.4429 | $24.96 | +1,557% |
| February, 2030 | $24.28 | $24.43 | $25.04 | +1,466% |
| March, 2030 | $18.39 | $19.50 | $23.82 | +1,087% |
| April, 2030 | $17.74 | $17.92 | $17.50 | +1,044% |
| May, 2030 | $17.64 | $17.55 | $17.24 | +1,038% |
| June, 2030 | $15.84 | $16.04 | $17.08 | +921.75% |
| July, 2030 | $13.33 | $13.58 | $14.90 | +759.72% |
| August, 2030 | $11.89 | $12.09 | $12.30 | +667.01% |
| September, 2030 | $25.53 | $10.98 | $23.49 | +1,547% |
| October, 2030 | $27.44 | $27.98 | $28.01 | +1,671% |
| November, 2030 | $25.62 | $26.32 | $26.93 | +1,553% |
| December, 2030 | $18.60 | $20.66 | $20.81 | +1,100% |
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):